Skip to main content
Erschienen in: Radiation Oncology 1/2010

Open Access 01.12.2010 | Methodology

Kypho-IORT - a novel approach of intraoperative radiotherapy during kyphoplasty for vertebral metastases

verfasst von: Frederik Wenz, Frank Schneider, Christian Neumaier, Uta Kraus-Tiefenbacher, Tina Reis, René Schmidt, Udo Obertacke

Erschienen in: Radiation Oncology | Ausgabe 1/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Instable and painful vertebral metastases in patients with progressive visceral metastases present a common therapeutic dilemma. We developed a novel approach to deliver intraoperative radiotherapy (IORT) during kyphoplasty and report the first treated case.

Methods/Results

60 year old patient with metastasizing breast cancer under chemotherapy presented with a newly diagnosed painful metastasis in the 12th thoracic vertebra. Under general anaesthesia, a bipedicular approach into the vertebra was chosen with insertion of specially designed metallic sleeves to guide the electron drift tube of the miniature X-ray generator (INTRABEAM, Carl Zeiss Surgical, Oberkochen, Germany). This was inserted with a novel sheet designed for this approach protecting the drift tube. A radiation dose of 8 Gy in 5 mm distance (50 kV X-rays) was delivered. The kyphoplasty balloons (KyphX, Kyphon Inc, Sunnyvale) were inflated after IORT and polymethylmethacrylate cement was injected. The whole procedure lasted less than 90 minutes.

Conclusion

In conclusion, this novel, minimally invasive procedure can be performed in standard operating rooms and may become a valuable option for patients with vertebral metastases providing immediate stability and local control. A phase I/II study is under way to establish the optimal dose prescription.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1748-717X-5-11) contains supplementary material, which is available to authorized users.

Competing interests

Carl Zeiss Surgical Oberkochen supports radiobiological research at University Medical Centre Mannheim.

Authors' contributions

FW, UO, FS: idea and concept; FW, FS, UKT, RS, UO: design and development; CN, UKT, TR, RS: patient selection and care; FW, CN, TR: writing of manuscript; FW, FS, CN, UKT, TR, RS; UO: final revision of manuscript. All authors have read and approved the final manuscript.

Background

It is a common therapeutic dilemma in the treatment of advanced stage cancer that progressive visceral metastases and instable and painful bone metastases are present simultaneously and require urgent treatment. However, due to potentiated toxicity, simultaneous treatment with full dose chemotherapy and fractionated radiotherapy is rarely possible. In addition, instability of the vertebral column may require prolonged periods of bed rest. We have therefore developed a novel approach to deliver intraoperative radiotherapy (IORT) during kyphoplasty in order to regain immediate stability, sterilize the metastasis and continue with chemotherapy without a delay of several weeks. Here we report about the first use of this novel approach (Kypho-IORT).

Results

A 60 year old patient with metastasizing breast cancer to the lung and mediastinal lymph nodes under docetaxel chemotherapy (75 mg/sqm q21d for 3 cycles) presented with a newly diagnosed painful metastasis in the 12th thoracic vertebra. There was an increased risk for a pathologic fracture due to the extent of the vertebral metastasis (see figure 1). The initial diagnosis of a receptor-positive lobular-invasive breast cancer (pT2 pN1a G2 her2neu FISH negative) in the left upper-outer quadrant was made 3 years ago. The patient received initially breast conserving surgery, axillary dissection, adjuvant chemotherapy (6 × FEC) and whole breast radiotherapy with boost (50 + 16 Gy) followed by endocrine therapy using letrozole. Visceral metastases were diagnosed three months ago during routine follow-up and palliative chemotherapy was initiated.
The kyphoplasty itself was performed according to the standard procedure with some minor modifications. In short, under general anaesthesia and after sterile preparation of the patient, a bipedicular approach was chosen (see figure 2). Specially designed metallic sleeves (5 mm diameter, 6 cm length) were inserted (see figure 3) to guide the electron drift tube (3.2 mm diameter) of the miniature X-ray generator (INTRABEAM, Carl Zeiss Surgical, Oberkochen, Germany). After verification of the position of the guiding sleeves using biplanar X-ray, the INTRABEAM system was inserted with a novel sheet (diameter 4.2 mm) designed for this approach protecting the drift tube (see figure 4 + 5). Special care was taken to avoid sheer and bending stress on the drift tube and the sheet. A radiation dose of 8 Gy in 5 mm distance (50 kV X-rays, corresponding to 27 Gy at 2 mm distance from surface of the radiation source) was delivered during about 90 seconds to the center of the metastasis. Examples of dose distributions depending on the position of the radiation source can be seen in figures 6 + 7. Afterwards, the INTRABEAM system was removed. The kyphoplasty balloons (KyphX, Kyphon Inc, Sunnyvale) were inflated with 300 PSI on either side and 2 × 4 ml polymethylmethacrylate (PMMA) cement were injected (KyphX, Kyphon Inc, Sunnyvale, see figure 8). The guiding sleeves were extracted and skin closure was done as usual. The whole procedure lasted less than 90 minutes. The patient was pain free on the day following the procedure and there was no visible radiation induced skin reaction.

Discussion

Percutaneous kyphoplasty and vertebroplasty are increasingly used [15]. It is a valuable treatment option for patients with painful and instable metastases to the vertebral column although its value for osteoporotic fractures has been recently questioned [6, 7]. Now it is possible to combine this procedure with the delivery of a high dose of intraoperative radiotherapy (IORT) providing immediate stability, pain relief and sterilization of the metastasis. Technically, vertebrae below the level of thoracic vertebra 3 are suitable for the Kypho-IORT approach when the metastasis is predominantly located in the vertebral body. A limited destruction of the dorsal corticalis is not a contraindication, however, special attention should be paid to avoid leakage of the PMMA into the spinal canal ("egg-shell technique"). Whether metastases in the pedicle can be approached with this technique remains to be determined based on the dose to the spinal cord and the stability of the positioning of the IORT device. External beam radiotherapy or radiosurgery [8, 9] even when combined with bisphosphonates do provide improved structural stability only after a prolonged period of time and the hazards of open radionuclides are avoided with this X-ray based approach [10]. A detailed discussion about different fractionation schedules for the treatment of spinal cord metastases can be found in a recent review [11]. This new application broadens the potential applications of the Intrabeam system, which is up to now mainly used for IORT for breast cancer [1214], and brain tumors [15]. Because long term experiences with this approach are not available at present, a phase I/II study is ongoing to establish the optimal dose presciption to provide local control.

Conclusion

IORT with low energy X-rays can be performed during kyphoplasty in standard operating rooms without the necessity of excessive radiation protection measures. As survival times of patients with many types of advanced cancer increase, the demand for this novel approach will potentially increase in the future.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

Carl Zeiss Surgical Oberkochen supports radiobiological research at University Medical Centre Mannheim.

Authors' contributions

FW, UO, FS: idea and concept; FW, FS, UKT, RS, UO: design and development; CN, UKT, TR, RS: patient selection and care; FW, CN, TR: writing of manuscript; FW, FS, CN, UKT, TR, RS; UO: final revision of manuscript. All authors have read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Hoffmann RT, Jakobs TF, Wallnöfer A, et al.: Percutaneous vertebroplasty (PV): indications, contraindications, and technique. Radiologe 2003,43(9):709-717. 10.1007/s00117-003-0947-yCrossRefPubMed Hoffmann RT, Jakobs TF, Wallnöfer A, et al.: Percutaneous vertebroplasty (PV): indications, contraindications, and technique. Radiologe 2003,43(9):709-717. 10.1007/s00117-003-0947-yCrossRefPubMed
2.
Zurück zum Zitat Jang JS, Lee SH: Efficacy of percutaneous vertebroplasty combined with radiotherapy in osteolytic metastatic spinal tumors. J Neurosurg Spine 2005,2(3):243-248. 10.3171/spi.2005.2.3.0243CrossRefPubMed Jang JS, Lee SH: Efficacy of percutaneous vertebroplasty combined with radiotherapy in osteolytic metastatic spinal tumors. J Neurosurg Spine 2005,2(3):243-248. 10.3171/spi.2005.2.3.0243CrossRefPubMed
3.
Zurück zum Zitat Ofluoglu O: Minimally invasive management of spinal metastases. Orthop Clin North Am 2009,40(1):155-168. 10.1016/j.ocl.2008.09.006CrossRefPubMed Ofluoglu O: Minimally invasive management of spinal metastases. Orthop Clin North Am 2009,40(1):155-168. 10.1016/j.ocl.2008.09.006CrossRefPubMed
4.
Zurück zum Zitat Sciubba DM, Nguyen T, Gokaslan ZL: Solitary vertebral metastsis. Orthop Clin North Am 2009,40(1):145-154. 10.1016/j.ocl.2008.09.003CrossRefPubMed Sciubba DM, Nguyen T, Gokaslan ZL: Solitary vertebral metastsis. Orthop Clin North Am 2009,40(1):145-154. 10.1016/j.ocl.2008.09.003CrossRefPubMed
5.
Zurück zum Zitat Wong J, Chow E, de Sa E, et al.: Immediate pain relief and improved structural stability after percutaneous vertebroplasty for a severely destructive vertebral compression fracture. J Palliat Med 2009,12(1):97-100. 10.1089/jpm.2009.9687CrossRefPubMed Wong J, Chow E, de Sa E, et al.: Immediate pain relief and improved structural stability after percutaneous vertebroplasty for a severely destructive vertebral compression fracture. J Palliat Med 2009,12(1):97-100. 10.1089/jpm.2009.9687CrossRefPubMed
6.
Zurück zum Zitat Buchbinder R, Osborne RH, Ebeling PR, et al.: A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009, 361: 557-568. 10.1056/NEJMoa0900429CrossRefPubMed Buchbinder R, Osborne RH, Ebeling PR, et al.: A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009, 361: 557-568. 10.1056/NEJMoa0900429CrossRefPubMed
7.
Zurück zum Zitat Kallmes DF, Comstock BA, Heagerty PJ, et al.: A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009, 361: 569-579. 10.1056/NEJMoa0900563PubMedCentralCrossRefPubMed Kallmes DF, Comstock BA, Heagerty PJ, et al.: A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009, 361: 569-579. 10.1056/NEJMoa0900563PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Gerszten PC, Welch WC: Cyberknife radiosurgery for metastatic spine tumors. Neurosurg Clin N Am 2004,15(4):491-501. 10.1016/j.nec.2004.04.013CrossRefPubMed Gerszten PC, Welch WC: Cyberknife radiosurgery for metastatic spine tumors. Neurosurg Clin N Am 2004,15(4):491-501. 10.1016/j.nec.2004.04.013CrossRefPubMed
9.
Zurück zum Zitat Rades D, Veninga T, Stalpers LJ, et al.: Outcome after radiotherapy alone for metastatic spinal cors comporession in patients with oligometastases. J Clin Oncol 2007,25(1):50-56. 10.1200/JCO.2006.08.7155CrossRefPubMed Rades D, Veninga T, Stalpers LJ, et al.: Outcome after radiotherapy alone for metastatic spinal cors comporession in patients with oligometastases. J Clin Oncol 2007,25(1):50-56. 10.1200/JCO.2006.08.7155CrossRefPubMed
10.
Zurück zum Zitat Cardoso ER, Ashamalla H, Weng L, et al.: Percutaneous tumor curretage and interstitial delivery of samarium-153 coupled with kyphoplasty for treatment of vertebral metastases. J Neurosurg Spine 2009,10(4):336-342. 10.3171/2008.11.SPINE0856CrossRefPubMed Cardoso ER, Ashamalla H, Weng L, et al.: Percutaneous tumor curretage and interstitial delivery of samarium-153 coupled with kyphoplasty for treatment of vertebral metastases. J Neurosurg Spine 2009,10(4):336-342. 10.3171/2008.11.SPINE0856CrossRefPubMed
11.
Zurück zum Zitat Souchon R, Wenz F, Sedlmayer F, et al.: DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC). Strahlenther Onkol 2009,185(7):417-424. 10.1007/s00066-009-2044-2CrossRefPubMed Souchon R, Wenz F, Sedlmayer F, et al.: DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC). Strahlenther Onkol 2009,185(7):417-424. 10.1007/s00066-009-2044-2CrossRefPubMed
12.
Zurück zum Zitat Vaidya JS, Baum M, D'Souza DP, et al.: Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 2001,12(8):1075-1080. 10.1023/A:1011609401132CrossRefPubMed Vaidya JS, Baum M, D'Souza DP, et al.: Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 2001,12(8):1075-1080. 10.1023/A:1011609401132CrossRefPubMed
13.
Zurück zum Zitat Vaidya JS, Hall-Craggs M, Baum M, et al.: Percutaneous minimally invasive stereotactic primary radiotherapy for breast cancer. Lancet Oncol 2002,3(4):252-253. 10.1016/S1470-2045(02)00717-9CrossRefPubMed Vaidya JS, Hall-Craggs M, Baum M, et al.: Percutaneous minimally invasive stereotactic primary radiotherapy for breast cancer. Lancet Oncol 2002,3(4):252-253. 10.1016/S1470-2045(02)00717-9CrossRefPubMed
14.
Zurück zum Zitat Kraus-Tiefenbacher U, Steil V, Bauer L, Melchert F, Wenz F: A novel device for intraoperative radiotherapy (IORT). Onkologie 2003, 26: 596-598. 10.1159/000074158CrossRefPubMed Kraus-Tiefenbacher U, Steil V, Bauer L, Melchert F, Wenz F: A novel device for intraoperative radiotherapy (IORT). Onkologie 2003, 26: 596-598. 10.1159/000074158CrossRefPubMed
15.
Zurück zum Zitat Cosgrove GR, Hochberg FH, Zervas NT, et al.: Interstitial irradiation of brain tumors, using a miniature radiosurgery device: initial experience. Neurosurgery 1997,40(3):518-523. 10.1097/00006123-199703000-00018PubMed Cosgrove GR, Hochberg FH, Zervas NT, et al.: Interstitial irradiation of brain tumors, using a miniature radiosurgery device: initial experience. Neurosurgery 1997,40(3):518-523. 10.1097/00006123-199703000-00018PubMed
Metadaten
Titel
Kypho-IORT - a novel approach of intraoperative radiotherapy during kyphoplasty for vertebral metastases
verfasst von
Frederik Wenz
Frank Schneider
Christian Neumaier
Uta Kraus-Tiefenbacher
Tina Reis
René Schmidt
Udo Obertacke
Publikationsdatum
01.12.2010
Verlag
BioMed Central
Erschienen in
Radiation Oncology / Ausgabe 1/2010
Elektronische ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-5-11

Weitere Artikel der Ausgabe 1/2010

Radiation Oncology 1/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.